Evidence-Based Medicine Center, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China.
Institute for Hospital Management, Tsinghua University, Shenzhen, China.
Int J Public Health. 2023 Jul 7;68:1605526. doi: 10.3389/ijph.2023.1605526. eCollection 2023.
This umbrella meta-analysis aims to provide comprehensive and synthesized evidence regarding the effectiveness and safety of COVID-19 vaccinations based on current studies. Studies from the Cochrane Library, PubMed, and EMBASE, published before 10 December 2021, were included in the analysis. The pooled results of effectiveness and safety were estimated and shown in forest plots. We included nineteen studies (fifteen studies regarding safety and nine regarding effectiveness) in the analysis. The mRNA vaccines, adenovirus vector vaccines, subunit vaccines, and inactivated vaccines were found to be effective; however, mRNA vaccines, adenovirus vector vaccines and subunit vaccines were associated with local adverse events and systemic events when compared with inactivated vaccines. Our study suggested that till date, COVID-19 vaccination is still a preferred pharmaceutical way to control the widespread pandemic. However, all reported adverse events should be revisited to provide further evidence for mass vaccinations.
这项伞式荟萃分析旨在根据现有研究提供关于 COVID-19 疫苗接种的有效性和安全性的全面综合证据。分析中纳入了 Cochrane 图书馆、PubMed 和 EMBASE 上发布的截至 2021 年 12 月 10 日之前的研究。有效性和安全性的汇总结果以森林图形式呈现。我们纳入了 19 项研究(15 项关于安全性,9 项关于有效性)进行分析。mRNA 疫苗、腺病毒载体疫苗、亚单位疫苗和灭活疫苗被证明是有效的;然而,与灭活疫苗相比,mRNA 疫苗、腺病毒载体疫苗和亚单位疫苗与局部不良事件和全身事件相关。我们的研究表明,迄今为止,COVID-19 疫苗接种仍然是控制广泛流行的首选药物方法。然而,应该重新审视所有报告的不良事件,为大规模接种提供进一步的证据。